Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now small index

Chronic Wounds clinical trials

3 of 5 indexed Chronic Wounds trials are currently recruiting.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Chronic Wounds: 5 US clinical trials tracked, 3 recruiting.

Chronic Wounds is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. The most active sponsor is University of Pittsburgh, running 2 of these trials.

Enrollment posture brief

Registry condition chronic-wounds

OPEN 3 | RECR 60% | LATE 0 | EARLY 0 | RANK #3391 | SPON 2

Volume-matched condition peers

Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Chronic Wounds (this)60%
Open-enrollment share among volume-matched conditions near Chronic Wounds

Chronic Wounds lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Chronic Wounds on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Chronic Wounds is recruiting above its size-band peers.

    3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Chronic Wounds research.

    University of Pittsburgh accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Most Chronic Wounds trials plan to enrol fewer than 100 people.

    Median target enrolment is 50 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.

  4. Chronic Wounds research leans observational.

    2 interventional and 3 observational studies make up this index (40% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Top Sponsors

University of Pittsburgh 2 trials
StimLabs 1 trials
Molnlycke Health Care AB 1 trials
Reprise Biomedical 1 trials

Named interventions

Most-linked intervention names on Chronic Wounds records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Normlgel Ag Device
1 trials
No Interventions Other
1 trials
Acellular Porcine-Derived Wound Matrix Device
1 trials

US sites by state

Facility locations filed on Chronic Wounds trials. A trial with sites in several states counts in each.

Pennsylvania 2 trials
Texas 1 trials
Oklahoma 1 trials
Georgia 1 trials
Florida 1 trials
Arizona 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Chronic Wounds page

5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Chronic Wounds condition card totals 5 registered trials; most-linked intervention Normlgel Ag; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.